These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23031290)

  • 1. Statins and atrial fibrillation in patients with left ventricular dysfunction: insights from the AF-CHF trial.
    Koutbi L; Roy D; Talajic M; Blondeau L; Franceschi F; Rivard L; Macle L; Andrade JG; Guerra PG; Thibault B; Dubuc M; Khairy P
    Int J Cardiol; 2013 May; 165(3):575-7. PubMed ID: 23031290
    [No Abstract]   [Full Text] [Related]  

  • 2. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
    Epstein EF
    Age Ageing; 2005 Mar; 34(2):196; author reply 196-7. PubMed ID: 15713873
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are we ready for a statin on our toast?
    DeSilvey DL
    Am J Geriatr Cardiol; 2006; 15(6):392-3. PubMed ID: 17086036
    [No Abstract]   [Full Text] [Related]  

  • 6. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
    J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
    Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
    Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
    Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
    Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antioxidant effects of statins may extend beyond atherosclerosis: potential benefits for atrial fibrillation and heart failure.
    Korantzopoulos P; Kokkoris S
    Atherosclerosis; 2004 Jul; 175(1):187. PubMed ID: 15186966
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure.
    Adabag AS; Nelson DB; Bloomfield HE
    Am Heart J; 2007 Dec; 154(6):1140-5. PubMed ID: 18035087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
    Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
    J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program.
    Joglar JA; Acusta AP; Shusterman NH; Ramaswamy K; Kowal RC; Barbera SJ; Hamdan MH; Page RL
    Am Heart J; 2001 Sep; 142(3):498-501. PubMed ID: 11526364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The atrial fibrillation paradox of heart failure.
    Shelton RJ; Clark AL; Kaye GC; Cleland JG
    Congest Heart Fail; 2010; 16(1):3-9. PubMed ID: 20078621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
    Vermes E; Tardif JC; Bourassa MG; Racine N; Levesque S; White M; Guerra PG; Ducharme A
    Circulation; 2003 Jun; 107(23):2926-31. PubMed ID: 12771010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?
    Cioffi G; De Feo S; Pulignano G; Del Sindaco D; Tarantini L; Stefenelli C; Opasich C
    Int J Cardiol; 2006 Feb; 107(2):220-4. PubMed ID: 16412800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and prevention of atrial fibrillation in patients with heart failure.
    Liu T; Li G; Korantzopoulos P; Goudevenos JA
    Int J Cardiol; 2009 Jul; 135(3):e83-4. PubMed ID: 18625529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
    Maggioni AP; Fabbri G; Lucci D; Marchioli R; Franzosi MG; Latini R; Nicolosi GL; Porcu M; Cosmi F; Stefanelli S; Tognoni G; Tavazzi L;
    Eur Heart J; 2009 Oct; 30(19):2327-36. PubMed ID: 19717850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of atrial fibrillation in heart failure].
    Le Heuzey JY; Marijon E; Otmani A; Lepillier A; Waintraub X; Lavergne T; Pornin M
    Therapie; 2009; 64(2):115-9. PubMed ID: 19664405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Upstream therapy of atrial fibrillation in patients with heart failure].
    Alboni P; Gianfranchi L; Pacchioni F
    G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of atrial fibrillation by statins: still unresolved?
    Crijns HJ
    Eur Heart J; 2009 Oct; 30(19):2302-3. PubMed ID: 19717849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.